Stock Analysis

Swedish Growth Companies With High Insider Ownership To Watch In July 2024

Published

As global markets experience fluctuations, with indices like the Russell 2000 showcasing notable gains, the Swedish market remains a point of interest for investors looking for growth opportunities. High insider ownership in Swedish companies often signals strong confidence from those who know the business best, making such stocks particularly intriguing in the current economic landscape.

Top 10 Growth Companies With High Insider Ownership In Sweden

NameInsider OwnershipEarnings Growth
CTT Systems (OM:CTT)16.9%21.6%
Biovica International (OM:BIOVIC B)18.5%73.8%
edyoutec (NGM:EDYOU)14.6%63.1%
Sileon (OM:SILEON)20.3%109.3%
KebNi (OM:KEBNI B)37.8%90.4%
Yubico (OM:YUBICO)37.5%43.8%
InCoax Networks (OM:INCOAX)18.1%104.9%
BioArctic (OM:BIOA B)34%50.9%
Calliditas Therapeutics (OM:CALTX)11.6%52.9%
SaveLend Group (OM:YIELD)23.3%103.4%

Click here to see the full list of 87 stocks from our Fast Growing Swedish Companies With High Insider Ownership screener.

We're going to check out a few of the best picks from our screener tool.

BioArctic (OM:BIOA B)

Simply Wall St Growth Rating: ★★★★★★

Overview: BioArctic AB (publ) focuses on developing biological drugs for central nervous system disorders in Sweden, with a market capitalization of SEK 20.85 billion.

Operations: The company generates SEK 252.21 million from its biotechnology segment.

Insider Ownership: 34%

Earnings Growth Forecast: 50.9% p.a.

BioArctic, a Swedish biopharmaceutical company, is poised for significant growth with expected revenue increases of 40.8% per year and forecasted profitability within three years. Despite trading at 66.9% below its estimated fair value, insider transactions have not shown substantial buying in recent months. Recent approvals in South Korea for its Alzheimer's treatment, Leqembi®, and ongoing collaborations with Eisai Co., Ltd., highlight its strategic advancements in neurodegenerative diseases.

OM:BIOA B Ownership Breakdown as at Jul 2024

Pandox (OM:PNDX B)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Pandox AB is a global hotel property company that owns, develops, and leases hotel properties, with a market capitalization of approximately SEK 38.33 billion.

Operations: The company generates its revenue primarily through two segments: own operation (SEK 3.27 billion) and rental agreements (SEK 3.82 billion).

Insider Ownership: 12.3%

Earnings Growth Forecast: 27.7% p.a.

Pandox AB, a Swedish hotel property company, has shown robust financial performance with recent quarterly earnings significantly surpassing previous figures. Despite a lower net profit margin compared to last year, the company's revenue and earnings growth are outpacing the broader Swedish market. However, challenges include a low forecasted return on equity and insufficient coverage of dividends and interest payments by earnings. Insider trading activity remains minimal over the past three months, indicating stable insider confidence in the company’s trajectory.

OM:PNDX B Earnings and Revenue Growth as at Jul 2024

Wallenstam (OM:WALL B)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Wallenstam AB (publ) is a Swedish property company with a market capitalization of approximately SEK 37.22 billion.

Operations: The company generates its revenues primarily from two segments: SEK 1.94 billion from Gothenburg and SEK 0.94 billion from Stockholm.

Insider Ownership: 35%

Earnings Growth Forecast: 55.3% p.a.

Wallenstam AB has turned profitable this year, with a significant recovery in earnings and revenue growth outpacing the Swedish market. Recent results show substantial improvement, with net income shifting from a loss to SEK 408 million over six months. Despite these gains, forecasted return on equity remains low at 4.4%. Insider activity has been moderate, lacking substantial volumes but showing more purchases than sales. The company is also enhancing its environmental credentials through sustainable property developments.

OM:WALL B Ownership Breakdown as at Jul 2024

Where To Now?

Ready To Venture Into Other Investment Styles?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Valuation is complex, but we're helping make it simple.

Find out whether Wallenstam is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com